- Home
- APXT vs ZVRA Comparison
APXT vs ZVRA Comparison
Compare APXT & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APXT | ZVRA |
|---|---|---|
| Founded | 2025 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.1M | 502.7M |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | APXT | ZVRA |
|---|---|---|
| Price | $9.95 | $8.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.71 |
| AVG Volume (30 Days) | 94.3K | ★ 1.0M |
| Earning Date | 01-01-0001 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $84,388,000.00 |
| Revenue This Year | N/A | $333.64 |
| Revenue Next Year | N/A | $43.58 |
| P/E Ratio | ★ N/A | $16.79 |
| Revenue Growth | N/A | ★ 244.60 |
| 52 Week Low | $9.87 | $6.19 |
| 52 Week High | $9.96 | $13.16 |
Technical Indicators
Market Signals| Indicator | APXT | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 75.40 | 54.06 |
| Support Level | $9.89 | $8.75 |
| Resistance Level | $9.94 | $9.60 |
| Average True Range (ATR) | 0.01 | 0.46 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 87.50 | 58.55 |
Price Performance
Historical ComparisonAbout APXT Apex Treasury Corporation Class A Ordinary Share
Apex Treasury Corp is a blank check company established for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.